EGFR and non-small cell lung carcinoma: Conversely, extending the chain length (e.g., 5as and 5at), reduced the EGFR TK inhibitory activity, which implies that the improved activity, observed during the EGFR-mutant NSCLC cell viability screening, was not caused by inhibition of EGFR.